End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 TWD | +1.14% | -0.80% | -.--% |
2019 | Tai-Ling Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
2019 | Tai Ling Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
Sales 2017 | 330M 10.13M 845M | Sales 2018 | 342M 10.49M 875M | Capitalization | 293M 8.98M 749M |
---|---|---|---|---|---|
Net income 2017 | -35M -1.07M -89.57M | Net income 2018 | 12M 368K 30.71M | EV / Sales 2017 | 1.12 x |
Net Debt 2017 | 68.44M 2.1M 175M | Net Debt 2018 | 100M 3.08M 257M | EV / Sales 2018 | 1.15 x |
P/E ratio 2017 |
-8.55
x | P/E ratio 2018 |
24.1
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
3.66% | Free-Float | 0% |
1 day | +1.14% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Fu Liu
CEO | Chief Executive Officer | - | 01/05/01 |
Tzu Hui Wang
DFI | Director of Finance/CFO | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Hsiung Lin
BRD | Director/Board Member | - | - |
Han Fei Lin
BRD | Director/Board Member | - | 12/15/12 |
Chi Li Chang
BRD | Director/Board Member | - | - |
- Stock Market
- Equities
- 8496 Stock